Midwife Licensure Exam Midwifery Pharmacology & Newborn Procedures — Midwifery Pharmacology — The Limited FormularyRevision Notes
Condensed revision notes for Midwifery Pharmacology — The Limited Formulary, built for the final weeks before the Midwife Licensure Exam 2026. These are the distilled key points you need when there is no time left for full study notes — just the concepts, formulas, and traps Professional Regulation Commission (PRC) — Board of Midwifery tests.
Exam context
For the Midwife Licensure Examination, Professional Regulation Commission (PRC) — Board of Midwifery tests Midwifery Pharmacology & Newborn Procedures under a "Core" label, with Midwifery Pharmacology — The Limited Formulary in the 1st slot across 4 chapters. Midwife Licensure Exam candidates must clear the 75% weighted average cut on the 2026 paper, which draws about a meaningful share of Midwifery Pharmacology & Newborn Procedures questions. Date to watch: April and November 2026 (expected).
Midwifery Pharmacology — The Limited Formulary - Revision Notes
Under Republic Act No. 7392 (The Philippine Midwifery Act of 1992), a registered midwife works from a short, defined list of essential drugs appropriate for primary maternal-newborn care at the Barangay Health Station (BHS), RHU, or lying-in clinic. The MLE tests whether you know exactly what is INSIDE and OUTSIDE this formulary. Think of it this way: if a drug supports a NORMAL birth or prevents a defined deficiency or infection, it belongs to the midwife. If it TREATS a disease or manages a complication beyond first-aid, the midwife's correct action is to REFER. Mastering this boundary — and the exact doses, routes, timing, and contraindications of every drug in the formulary — is the single most important pharmacology skill for the board exam and for patient safety in real community practice.
Sections
Exam Tips
- When an MLE question asks 'What is the midwife's first action?' for a complication like eclampsia or severe PPH, the answer always includes 'REFER' — with the loading dose as the pre-referral stabilizing measure.
- If a question names an unfamiliar drug, ask yourself: 'Does this fit the midwife's normal-birth/prevention role?' If not, the answer is likely REFER.
Key Points
- RA 7392 defines the midwife as an independent primary provider of NORMAL maternal, newborn, and family-planning care — not a prescriber for disease management.
- The midwife's formulary covers: oxytocics (AMTSL and PPH first-aid), newborn drugs (Vitamin K, eye prophylaxis), micronutrients (iron, folic acid, Vitamin A), vaccines (Td/TT), family planning drugs (COCs, POPs, DMPA), and one emergency anticonvulsant loading dose (MgSO4).
- Outside the formulary: antibiotics for ongoing infection treatment, labor induction/augmentation drugs, anesthesia, antihypertensives, insulin, anticoagulants, and any drug that treats a diagnosed disease rather than supporting normal birth.
- The safest MLE heuristic: 'Does this drug support NORMAL birth or prevent a defined deficiency/infection?' YES = midwife can give it. NO = REFER.
Definitions
Term
Limited Formulary
Definition
The specific, legally authorized short list of drugs a registered midwife in the Philippines may administer independently in the community setting.
Importance
Defines the legal and clinical boundaries of midwifery practice; violations may constitute unauthorized practice of medicine.
Term
Primary Care Setting
Definition
The BHS (Barangay Health Station), RHU (Rural Health Unit), or accredited lying-in clinic where the midwife provides first-level maternal-newborn services.
Importance
Context determines which drugs are available and appropriate; the formulary is designed for these resource-limited settings.
Section Title
Why the Midwife Has a Limited Formulary
Common Mistakes
- Thinking the midwife can give antibiotics for treatment of infection — she can only give a pre-referral stabilizing dose under specific protocol, then REFER.
- Confusing 'administer' with 'prescribe' — midwives administer from a defined list; they do not prescribe independently.
- Forgetting that any drug used to TREAT a complication (e.g., antihypertensives for severe hypertension) is outside the midwife's scope — detect and REFER.
Formulas
Example
Inday delivers her baby at the BHS. The midwife checks — no second twin felt. Within 1 minute, she gives oxytocin 10 IU IM into the deltoid. This is AMTSL Step 1.
Formula
Oxytocin AMTSL: 10 IU IM within 1 minute of birth
Variables
IU = International Units; IM = Intramuscular; given into the deltoid or thigh
Application
Routine prevention of PPH after every vaginal delivery at BHS or lying-in clinic
Example
At a remote barangay with no refrigerator, the midwife uses misoprostol 600 mcg orally as the AMTSL uterotonic.
Formula
Misoprostol AMTSL alternative: 600 mcg orally immediately after birth
Variables
mcg = micrograms; given orally (swallowed or sublingually per protocol)
Application
Used in communities without cold-chain refrigeration where oxytocin cannot be stored at 2–8°C
Exam Tips
- Board exam favorite: 'Drug of choice for AMTSL?' Answer: Oxytocin 10 IU IM within 1 minute of birth.
- Always pair the oxytocin answer with the reason: 'Does not raise blood pressure.'
- Ergometrine contraindication questions are very common — memorize: hypertension, pre-eclampsia, eclampsia, heart disease = CONTRAINDICATED.
- For PPH priority order in MLE: REFER + call for help → massage uterus → give oxytocin → empty bladder → check for tears.
Key Points
- Postpartum hemorrhage (PPH) is the NUMBER ONE direct cause of maternal death in the Philippines — oxytocics are the most critical drugs in the midwife's formulary.
- AMTSL (Active Management of the Third Stage of Labor) has THREE components: (1) Oxytocin 10 IU IM within 1 minute of birth (after ruling out second twin), (2) Controlled cord traction with counter-pressure on the uterus during a contraction, (3) Uterine massage after placenta delivery, then every 15 minutes for 2 hours.
- Oxytocin 10 IU IM is the DRUG OF CHOICE for AMTSL because it is effective AND does NOT raise blood pressure — safe even when BP status is unknown.
- Ergometrine 0.2 mg IM is SECOND-LINE for PPH and is ABSOLUTELY CONTRAINDICATED in hypertension, pre-eclampsia/eclampsia, and heart disease because it causes vasoconstriction and raises BP.
- Misoprostol 600 mcg orally after birth is an accepted AMTSL alternative where there is no cold chain (heat-stable advantage); 800 mcg orally may be used for PPH treatment per DOH/WHO community protocols.
- Priority actions for PPH: REFER, massage uterus, give oxytocin, empty the bladder, check for lacerations/tears.
- Oxytocin for LABOR INDUCTION or AUGMENTATION is a PHYSICIAN ACT — the midwife NEVER gives oxytocin before the baby is born to speed up labor. This can cause uterine rupture and fetal death.
Definitions
Term
AMTSL (Active Management of the Third Stage of Labor)
Definition
A three-component evidence-based protocol to prevent PPH: uterotonic within 1 minute of birth, controlled cord traction, and uterine massage after placenta delivery.
Importance
Reduces PPH risk by up to 60%; the midwife is responsible for correctly performing all three steps at every delivery.
Term
Oxytocin
Definition
A synthetic hormone that stimulates uterine contractions; the WHO/DOH drug of choice for AMTSL and PPH, given as 10 IU IM after delivery of the baby.
Importance
Does not raise BP — preferred over ergometrine for routine use because BP status at time of delivery may be unknown.
Term
Ergometrine (Methylergometrine)
Definition
An ergot alkaloid uterotonic given as 0.2 mg IM; second-line for PPH but contraindicated in hypertension, pre-eclampsia, and heart disease.
Importance
MLE frequently tests the contraindication: NEVER give ergometrine to a hypertensive woman — it can cause stroke or eclampsia.
Term
Misoprostol
Definition
A prostaglandin E1 analogue in tablet form; heat-stable (no cold chain needed); used as an AMTSL alternative (600 mcg orally) or PPH treatment (800 mcg orally) per community protocol.
Importance
Critical advantage: heat-stable — ideal for remote barangay settings without refrigeration.
Section Title
Oxytocics — The Core of AMTSL
Common Mistakes
- Giving oxytocin BEFORE the baby is born to 'help labor progress' — this is the most dangerous error; it is a physician act and can rupture the uterus.
- Giving ergometrine to a woman with high blood pressure or unknown BP — always check BP history before ergometrine.
- Forgetting to rule out a second twin before giving the uterotonic — giving it with a second baby inside can trap the baby.
- Thinking AMTSL is only the uterotonic injection — it has THREE components; all must be performed.
- Confusing misoprostol doses: 600 mcg for prevention (AMTSL), 800 mcg for treatment (PPH).
Formulas
Example
Baby Jose is born at 38 weeks, weighing 3.1 kg. He receives Vitamin K1 1 mg IM into his right anterolateral thigh within the first hour. Baby Maria is born at 32 weeks, weighing 1.3 kg (preterm, LBW) — she receives 0.5 mg IM.
Formula
Vitamin K1: 1 mg IM (term, ≥1.5 kg) OR 0.5 mg IM (preterm/LBW, <1.5 kg)
Variables
mg = milligrams; IM = intramuscular into vastus lateralis (anterolateral thigh)
Application
Single dose given to every newborn to prevent VKDB (bleeding due to low clotting factor activity at birth)
Exam Tips
- MLE will test: 'Where do you inject Vitamin K in a newborn?' Answer: Anterolateral thigh (vastus lateralis), NOT the deltoid.
- Dose differentiation is frequently tested: ≥1.5 kg = 1 mg; <1.5 kg = 0.5 mg.
- Eye prophylaxis question often asks about the agent — answer: erythromycin 0.5% ophthalmic ointment per DOH protocol.
- Remember the sequence: Unang Yakap steps first (dry, skin-to-skin, delayed cord clamping at 1–3 min, early breastfeeding) → THEN eye ointment and Vitamin K within the first hour.
Key Points
- Every newborn must receive TWO drugs at birth (as part of Unang Yakap/EINC): Vitamin K1 IM and eye prophylaxis.
- Vitamin K1 (phytomenadione) prevents Vitamin K Deficiency Bleeding (VKDB), formerly called hemorrhagic disease of the newborn.
- Vitamin K1 dose: 1 mg IM for term infants (birth weight ≥ 1.5 kg); 0.5 mg IM for preterm or LBW infants (birth weight < 1.5 kg). Injection site: anterolateral thigh (vastus lateralis muscle).
- Eye prophylaxis (Credé's prophylaxis) prevents ophthalmia neonatorum — gonococcal and chlamydial conjunctivitis from maternal genital tract.
- DOH-preferred eye prophylaxis agent: erythromycin 0.5% ophthalmic ointment (thin ribbon in each lower conjunctival sac). Alternative: tetracycline 1% ointment.
- IMPORTANT: Apply eye prophylaxis AFTER the eye-to-eye bonding and skin-to-skin contact. Do NOT irrigate the eyes after applying the ointment.
- Timing: Vitamin K and eye ointment are given within the first hour after birth (after the initial Unang Yakap steps: dry, skin-to-skin, cord clamp at 1–3 minutes, early breastfeeding initiation).
Definitions
Term
VKDB (Vitamin K Deficiency Bleeding)
Definition
A potentially fatal bleeding disorder in newborns caused by insufficient Vitamin K, which is needed to activate clotting factors II, VII, IX, and X; prevented by a single IM dose of Vitamin K1 at birth.
Importance
Without prophylaxis, VKDB can cause intracranial hemorrhage, GI bleeding, or death — Vitamin K injection is mandatory for every newborn.
Term
Ophthalmia Neonatorum
Definition
Conjunctivitis in a newborn, most commonly caused by Neisseria gonorrhoeae or Chlamydia trachomatis acquired during passage through the birth canal; prevented by erythromycin 0.5% ophthalmic ointment.
Importance
If untreated, gonococcal ophthalmia can cause corneal ulceration and blindness — prophylaxis is a medico-legal requirement.
Term
Credé's Prophylaxis
Definition
Eye prophylaxis for every newborn using ophthalmic ointment (erythromycin 0.5% or tetracycline 1%) applied to the lower conjunctival sac of each eye shortly after birth.
Importance
Named after Carl Credé who introduced silver nitrate for this purpose; modern practice uses antibiotic ointment.
Section Title
Newborn Drugs — Vitamin K and Eye Prophylaxis
Common Mistakes
- Giving Vitamin K1 into the deltoid — correct site is the anterolateral thigh (vastus lateralis) in newborns, NOT the arm.
- Using the same dose (1 mg) for preterm/LBW infants — the correct dose for birth weight < 1.5 kg is 0.5 mg.
- Irrigating the eyes after eye ointment — do NOT rinse the eyes; the ointment needs to stay in contact with the conjunctiva.
- Applying eye ointment before skin-to-skin bonding — per Unang Yakap, ointment is applied after bonding and drying steps.
- Confusing silver nitrate (historical) with the current DOH-preferred agent erythromycin 0.5% ophthalmic ointment.
Formulas
Example
Ate Rose is 12 weeks pregnant and attends her first ANC at the RHU. The midwife gives her a 3-month supply of ferrous sulfate + folic acid (60 mg + 400 mcg) and instructs her to take one tablet daily, preferably with citrus juice.
Formula
Iron-Folic Acid: 60 mg elemental iron + 400 mcg folic acid once daily
Variables
mg = milligrams (iron); mcg = micrograms (folic acid); once daily throughout pregnancy + 3 months postpartum
Application
Routine supplementation for ALL pregnant women at every antenatal visit; increases to twice daily if anemia is confirmed
Exam Tips
- Memorize the exact dose: 60 mg elemental iron + 400 mcg folic acid ONCE daily.
- High-yield: Vitamin A is SAFE postpartum (200,000 IU) but TERATOGENIC in pregnancy — this distinction is frequently tested.
- Duration of iron supplementation: throughout pregnancy AND 3 months postpartum — the postpartum continuation is often forgotten.
Key Points
- The midwife dispenses iron-folic acid to every pregnant woman as routine antenatal care — this is a core RHU/BHS function.
- Standard DOH dose: 60 mg elemental iron + 400 mcg (0.4 mg) folic acid ONCE DAILY throughout pregnancy and for 3 months postpartum.
- For women with confirmed anemia, the iron dose may be increased to TWICE DAILY under protocol.
- Folic acid's most critical role: prevents neural tube defects (NTDs) — ideally started at least 1 month BEFORE conception, but given throughout pregnancy.
- HIGH-DOSE Vitamin A (≥ 10,000 IU daily) is ABSOLUTELY CONTRAINDICATED during pregnancy — it is teratogenic and can cause fetal malformations.
- Vitamin A postpartum (where current DOH policy allows): 200,000 IU capsule given to the mother within the first weeks after delivery — NOT during pregnancy.
- Counseling point for iron: take on an empty stomach if tolerated (better absorption); Vitamin C-rich foods enhance absorption; tea, coffee, and calcium-rich foods reduce absorption.
Definitions
Term
Elemental Iron
Definition
The actual amount of absorbable iron in a supplement; 60 mg elemental iron is the standard antenatal dose, provided as ferrous sulfate 325 mg (which contains 60 mg elemental iron).
Importance
MLE may ask for elemental iron dose (60 mg), not the tablet weight — know the difference.
Term
Neural Tube Defect (NTD)
Definition
Serious birth defects of the brain and spine (e.g., spina bifida, anencephaly) caused by failure of the neural tube to close; prevented by adequate folic acid before and during early pregnancy.
Importance
Key reason why folic acid supplementation ideally begins pre-conception and continues throughout pregnancy.
Section Title
Micronutrient Supplements — Iron, Folic Acid, and Vitamin A
Common Mistakes
- Giving high-dose Vitamin A to a pregnant woman — it is teratogenic; only postpartum women receive the 200,000 IU dose.
- Stopping iron supplementation after delivery — it should continue for 3 months postpartum to replenish stores.
- Confusing folic acid dose: the standard is 400 mcg (0.4 mg), not 4 mg (which is the high-risk dose for women with previous NTD pregnancy — physician-directed).
- Forgetting to counsel on factors that affect iron absorption (enhancers: Vitamin C; inhibitors: tea, coffee, dairy, antacids).
Formulas
Example
Nena is a primigravida at her first prenatal visit at 10 weeks AOG. She has no prior TT immunization. The midwife gives TT1 today and schedules TT2 at least 4 weeks later (before delivery) to ensure the current pregnancy is protected.
Formula
Td: 0.5 mL IM per dose, deltoid; 5-dose series
Variables
mL = milliliters; IM = intramuscular; deltoid = upper arm injection site
Application
Protection against maternal and neonatal tetanus; each subsequent dose extends duration of immunity
Exam Tips
- High-yield MLE: 'Which dose first protects the current pregnancy?' Answer: TT2 (at least 4 weeks after TT1).
- Memorize the protection duration sequence: TT2 = 3 years, TT3 = 5 years, TT4 = 10 years, TT5 = lifetime.
- Dose: always 0.5 mL IM into the deltoid — this exact figure is tested.
Key Points
- The midwife administers Td (tetanus-diphtheria) vaccine to pregnant women to prevent maternal and neonatal tetanus (MNT) — a major cause of preventable neonatal death.
- Dose: 0.5 mL IM into the deltoid muscle.
- Classic TT1–TT5 schedule: TT1 (first contact/as early as possible in pregnancy, no protection yet) → TT2 (≥4 weeks after TT1, ~3 years protection, protects current pregnancy) → TT3 (≥6 months after TT2, ~5 years protection) → TT4 (≥1 year after TT3, ~10 years protection) → TT5 (≥1 year after TT4, lifetime/all childbearing years protection).
- A woman who has completed 5 doses (fully immunized) and her newborn are protected against neonatal tetanus.
- At a minimum, a pregnant woman needs TT2 (at least 4 weeks before delivery) to protect the current pregnancy.
- The midwife screens for vaccination history before giving each dose and records on the mother's health card and FHSIS.
Definitions
Term
Neonatal Tetanus (MNT — Maternal and Neonatal Tetanus)
Definition
A fatal infection of newborns caused by Clostridium tetani entering through an unclean umbilical cord stump; prevented by maternal Td immunization (passive antibody transfer to fetus) and clean cord care.
Importance
Neonatal tetanus is a key preventable cause of neonatal death; the midwife plays a direct role in prevention through vaccination and clean delivery practices.
Term
Td (Tetanus-Diphtheria) Vaccine
Definition
The current DOH tetanus-containing vaccine for pregnant women (replaces older TT-only formulation); also provides protection against diphtheria. Given as 0.5 mL IM.
Importance
MLE questions may still use 'TT' terminology for the scheduling logic — know both TT and Td terminology.
Section Title
Immunizing Agents — Tetanus-Diphtheria (Td) Vaccine
Common Mistakes
- Forgetting that TT1 gives NO protection — protection starts with TT2 (at least 4 weeks after TT1). Giving only TT1 does not protect the pregnancy.
- Giving the wrong injection site — Td is given in the DELTOID (upper arm), not the thigh (thigh is for newborn Vitamin K).
- Confusing the dose intervals — TT2: ≥4 weeks; TT3: ≥6 months; TT4 and TT5: ≥1 year each.
- Not screening vaccination history — a woman who already has 2–5 doses does not need to restart the series.
Formulas
Example
Maria is exclusively breastfeeding her 6-week-old baby and wants to use injectable contraception. The midwife gives DMPA 150 mg IM and schedules the next injection 3 months (13 weeks) later.
Formula
DMPA: 150 mg IM every 3 months (every 13 weeks)
Variables
mg = milligrams; IM = intramuscular (usually deltoid or gluteal); every 3 months = 4 injections per year
Application
Highly effective reversible contraception; preferred for breastfeeding women because it is progestin-only (no estrogen to suppress milk)
Exam Tips
- MLE frequently asks: 'A breastfeeding mother wants contraception — what is appropriate?' Answer: POP or DMPA (progestin-only).
- DMPA dose and interval: 150 mg IM every 3 months — memorize both numbers.
- For COC contraindications, remember the mnemonic ACHES: Abdominal pain (severe), Chest pain, Headache (severe/migraine with aura), Eye changes (vision disturbances), Severe leg pain (thromboembolism) — these are warning signs requiring referral.
Key Points
- The midwife provides contraceptive counseling and supplies the following: COCs (combined oral contraceptives), POPs (progestin-only pills), DMPA injectable, and condoms.
- DMPA (depot medroxyprogesterone acetate): 150 mg IM every 3 months (4×/year). Given by IM injection.
- COCs are avoided in: smokers over 35 years old, uncontrolled hypertension, history of thromboembolism (blood clots), migraine with aura, and liver disease.
- COCs are NOT the first choice for BREASTFEEDING women — estrogen suppresses milk production. Instead, use POPs or DMPA (progestin-only methods are safe during lactation).
- POPs: taken daily without a pill-free interval; must be taken at the same time each day. Safe for breastfeeding women.
- IUD insertion and subdermal implant insertion require specific training/certification beyond basic midwifery — midwife REFERS for these.
- Midwife must counsel on proper use, benefits, side effects, and warning signs for each method.
Definitions
Term
COC (Combined Oral Contraceptive)
Definition
A pill containing both estrogen and progestin; taken daily for 21 days followed by a 7-day pill-free interval; highly effective but contraindicated in breastfeeding, hypertension, smoking over 35, and thromboembolic risk.
Importance
The midwife must screen for COC contraindications at every FP visit — missed contraindications can cause serious complications.
Term
POP (Progestin-Only Pill / Mini-Pill)
Definition
An oral contraceptive containing only progestin; taken daily without a pill-free interval; safe for breastfeeding women and those with estrogen contraindications.
Importance
The preferred oral contraceptive for lactating women — does not suppress breast milk production.
Term
DMPA (Depot Medroxyprogesterone Acetate)
Definition
An injectable progestin-only contraceptive given as 150 mg IM every 3 months; highly effective, long-acting, and safe during breastfeeding.
Importance
Very common in Philippine community FP programs — the midwife administers this routinely at BHS/RHU.
Section Title
Family Planning Drugs Within the Midwife's Scope
Common Mistakes
- Giving COCs to a breastfeeding woman — the estrogen component reduces breast milk; use POPs or DMPA instead.
- Giving COCs to a hypertensive woman or a smoker over 35 — these are contraindications; refer for appropriate method.
- Forgetting that IUD and implant insertion are NOT in the basic midwife's scope without specific additional training/certification.
- Scheduling DMPA injections incorrectly — the interval is every 3 months (13 weeks), not every 2 months.
Formulas
Example
Lourdes, 32 weeks pregnant, has severe headache, BP 170/110 mmHg, and 3+ proteinuria. She then has a seizure. The midwife gives MgSO4 4 g IV slow over 15 minutes + 5 g deep IM each buttock, checks RR, urine output, and patellar reflex, then IMMEDIATELY arranges ambulance referral to the district hospital (BEmONC facility).
Formula
MgSO4 Loading Dose: 4 g IV (20% solution over 5–20 min) + 10 g IM (5 g in each buttock as 50% solution + 1 mL 2% lignocaine per side)
Variables
g = grams; IV = intravenous; IM = intramuscular; 20% solution = 20 g MgSO4 per 100 mL; 50% solution = 50 g MgSO4 per 100 mL
Application
Pre-referral emergency loading dose for eclampsia or severe pre-eclampsia; given by midwife ONCE before urgent referral
Example
During transport, the midwife notes the patient's RR dropped to 10/min and the patellar reflex is absent — she stops MgSO4 and gives calcium gluconate 10 mL of 10% solution slowly IV.
Formula
Antidote: Calcium gluconate 1 g = 10 mL of 10% calcium gluconate slow IV
Variables
g = grams; mL = milliliters; 10% solution = 10 g per 100 mL; slow IV = given slowly over 3 minutes
Application
Given immediately when MgSO4 toxicity is suspected (respiratory rate < 12, loss of knee-jerk reflex, oliguria)
Exam Tips
- This is one of the MOST HEAVILY TESTED topics in MLE pharmacology — memorize every number: 4 g IV, 5 g each buttock (10 g IM), 20% IV, 50% IM, 1 mL 2% lignocaine.
- Three safety signs mnemonic: R-U-K — Respiration (≥12/min), Urine (≥30 mL/hr), Knee-jerk (present). If ANY is absent/low = STOP MgSO4.
- Antidote: Calcium gluconate 1 g (10 mL of 10%) slow IV — know both the drug name AND the dose.
- The MLE may describe a patient with absent knee-jerk or RR of 10 and ask 'What should the midwife do?' Answer: Stop MgSO4, give calcium gluconate 1 g IV.
Key Points
- MgSO4 is the midwife's ONE authorized emergency drug for severe pre-eclampsia and eclampsia — given as the LOADING DOSE before and during URGENT REFERRAL to a higher facility.
- The midwife gives the LOADING DOSE ONLY. The maintenance dose is a physician/hospital responsibility.
- Loading regimen (Pritchard/DOH standard): 4 g MgSO4 (as 20% solution) slow IV over 5–20 minutes, PLUS 5 g MgSO4 (as 50% solution) deep IM into EACH buttock (10 g total IM), each IM dose mixed with 1 mL of 2% lignocaine to reduce injection pain.
- BEFORE each dose and every 4 hours during transport, CHECK the THREE SAFETY SIGNS: (1) Respiratory rate ≥ 12–16 breaths/min, (2) Urine output ≥ 30 mL/hr (or ≥ 100 mL/4 hours), (3) Patellar (knee-jerk) reflex PRESENT.
- MgSO4 TOXICITY signs: respiratory depression (RR < 12), loss of patellar reflex, oliguria — STOP MgSO4 immediately.
- ANTIDOTE for MgSO4 toxicity: Calcium gluconate 1 g (10 mL of 10% solution) slow IV — always have this ready when giving MgSO4.
- After the loading dose: REFER IMMEDIATELY to BEmONC/CEmONC facility — do not delay transport.
Definitions
Term
Eclampsia
Definition
Grand mal seizures in a woman with pre-eclampsia (hypertension + proteinuria in pregnancy) or in the postpartum period, not attributable to other causes; a life-threatening obstetric emergency requiring immediate MgSO4 and referral.
Importance
The midwife's role: detect signs of severe pre-eclampsia, give MgSO4 loading dose, and REFER urgently — she does NOT manage eclampsia independently.
Term
Patellar Reflex (Knee-Jerk Reflex)
Definition
The reflex elicited by tapping the patellar tendon below the kneecap; if ABSENT, it indicates MgSO4 toxicity (magnesium level too high) and the drug must be stopped.
Importance
One of the three mandatory safety checks before every MgSO4 dose — an absent knee-jerk is the earliest sign of toxicity.
Term
Lignocaine (Lidocaine)
Definition
A local anesthetic mixed with the IM dose of MgSO4 (1 mL of 2% lignocaine per 5 g MgSO4 IM) to reduce the pain of the deep IM injection.
Importance
MLE may ask why lignocaine is added to the IM MgSO4 — the answer is pain reduction at the injection site.
Section Title
The One Emergency Anticonvulsant — Magnesium Sulfate (MgSO4)
Common Mistakes
- Thinking the midwife gives the MAINTENANCE dose — she gives ONLY the LOADING dose before referral. Maintenance is hospital/physician responsibility.
- Forgetting the THREE safety signs — giving MgSO4 without checking RR, urine output, and patellar reflex is dangerous.
- Not having calcium gluconate ready — it MUST be prepared and accessible whenever MgSO4 is given.
- Confusing the solutions: IV dose uses 20% MgSO4; IM dose uses 50% MgSO4.
- Delaying referral to 'observe the patient' after the loading dose — after MgSO4, IMMEDIATE referral is mandatory.
Exam Tips
- If the MLE asks about oxytocin and the baby is NOT yet born, the answer is almost always REFER — unless the scenario is clearly about AMTSL (after birth) or PPH.
- For antibiotic questions: if the scenario says the midwife is in a remote area and the woman has signs of sepsis, the answer may include 'give pre-referral antibiotic dose AND immediately refer' — not 'prescribe antibiotics for treatment.'
- Anti-hypertensives = PHYSICIAN only — the midwife detects elevated BP, monitors, and REFERS urgently for severe hypertension (≥ 160/110 mmHg).
Key Points
- A midwife REFERS to a physician for any drug that TREATS a disease or manages a complication beyond first-aid stabilization.
- NEVER: Oxytocin or any uterotonic to INDUCE or AUGMENT labor before the baby is born — this is a physician act; incorrect use can cause uterine rupture and fetal death.
- NEVER: Antibiotics for ongoing treatment of infection (a pre-referral first dose under specific protocol is a stabilizing measure, not independent treatment).
- NEVER: General or regional anesthesia (spinal, epidural), or narcotics/controlled analgesics.
- NEVER: Antihypertensives (e.g., hydralazine, nifedipine) — detect high BP and REFER; the midwife does not independently adjust BP medications.
- NEVER: Insulin, anticoagulants (heparin, warfarin), corticosteroids for disease management, or other chronic-disease drugs.
- NEVER: Ergometrine in a known hypertensive woman — this is a drug-specific absolute prohibition.
- Rule of thumb: If you are unsure whether a drug is in the midwife's scope, ask: 'Is this for NORMAL birth support OR prevention of a defined deficiency/infection?' If YES — check the formulary. If NO — the answer is REFER.
Definitions
Term
Labor Induction
Definition
Artificially starting labor before it begins spontaneously, using oxytocin IV or other methods — this is strictly a PHYSICIAN ACT and is outside the midwife's scope.
Importance
The MLE frequently tests this boundary — giving oxytocin to induce labor is NOT authorized for the midwife and is a patient safety violation.
Term
Labor Augmentation
Definition
Stimulating or accelerating labor that has already started but is progressing slowly, using oxytocin IV — also a PHYSICIAN ACT outside the midwife's independent scope.
Importance
Distinguish from AMTSL (oxytocin after birth to prevent PPH) — AMTSL oxytocin is after the baby; augmentation oxytocin is during labor (before baby is born).
Section Title
Prohibited Categories — What the Midwife May NOT Give
Common Mistakes
- Thinking the midwife can 'just give a little oxytocin to speed up a slow labor' — this is one of the most dangerous errors in midwifery; it can rupture the uterus.
- Confusing 'pre-referral first-dose antibiotic' (acceptable emergency measure) with ongoing antibiotic treatment (physician responsibility).
- Thinking that because the midwife can give MgSO4 for eclampsia, she can also give antihypertensives — she cannot; MgSO4 is anticonvulsant, not antihypertensive.
Exam Tips
- The 7 Rights are tested in professional practice questions — know all seven.
- Anaphylaxis treatment: Epinephrine (adrenaline) 0.3–0.5 mg IM — this specific dose may be tested.
- Cold chain question: If oxytocin was not refrigerated, it may be degraded — use misoprostol (heat-stable) as an alternative in such settings.
Key Points
- The 7 RIGHTS of medication: Right PATIENT, Right DRUG, Right DOSE, Right ROUTE, Right TIME, Right DOCUMENTATION, Right to REFUSE (client informed consent).
- COLD CHAIN: Vaccines and oxytocin must be stored at 2–8°C. Check cold-chain integrity before every use. If cold chain is broken, the drug may be ineffective (vaccines) or degraded (oxytocin).
- Use STERILE SINGLE-USE needles and syringes for every injection — never reuse.
- CORRECT INJECTION SITES: Deltoid = vaccines (Td) and DMPA; Anterolateral thigh (vastus lateralis) = newborn Vitamin K; Deep IM gluteal = MgSO4 maintenance (hospital); Vastus lateralis or deltoid = oxytocin.
- SHARPS DISPOSAL: All used needles and syringes go directly into a puncture-proof sharps container — never recap needles with two hands.
- Watch for ANAPHYLAXIS after any injection (within 15–30 minutes): flushing, urticaria, difficulty breathing, hypotension. Treatment: epinephrine (adrenaline) 0.3–0.5 mg IM — have it available whenever giving injectable drugs.
- DOCUMENTATION: Record every drug given on the mother's/newborn's health record (MCH book, delivery record) and in the FHSIS registers — medicolegally required.
- Always check EXPIRY DATE and DRUG INTEGRITY before administration.
Definitions
Term
Cold Chain
Definition
The system of refrigerated storage and transport that maintains vaccines and heat-sensitive drugs (e.g., oxytocin) at 2–8°C from manufacture to point of use; broken cold chain means the drug may no longer be effective.
Importance
The midwife is responsible for cold-chain maintenance at the BHS level — using improperly stored vaccines wastes resources and leaves patients unprotected.
Term
Anaphylaxis
Definition
A severe, potentially life-threatening allergic reaction occurring within minutes of drug/vaccine injection, characterized by urticaria, angioedema, bronchospasm, and hypotension; treated immediately with epinephrine (adrenaline) 0.3–0.5 mg IM.
Importance
The midwife must always have epinephrine available when giving any injectable drug and must know how to recognize and respond to anaphylaxis.
Section Title
Principles of Safe Medication Administration
Common Mistakes
- Recapping needles with two hands — always use the one-hand scoop method or a needle recapper to prevent needlestick injuries.
- Not checking expiry dates — expired drugs may be ineffective or harmful.
- Skipping documentation — incomplete records are a medicolegal risk and compromise continuity of care.
- Not observing the patient for 15–30 minutes after injection for signs of anaphylaxis.
Connections
- AMTSL + PPH Prevention links to EINC/Unang Yakap — the third stage of labor protocol is integrated into the Unang Yakap four core steps (immediate drying, skin-to-skin, early cord clamping at 1–3 minutes, and early breastfeeding), with AMTSL oxytocin as a parallel action.
- MgSO4 loading dose connects to BEmONC competencies — the midwife giving the loading dose before referral is a core BEmONC/MNCHN skill for the pre-referral stabilization of an eclamptic woman.
- Vitamin K1 and eye prophylaxis are integral components of the EINC/Unang Yakap protocol — they are Step 2 actions (within the first 90 minutes) that follow the immediate newborn care steps.
- Iron-folic acid supplementation links to ANC (Antenatal Care) quality standards — dispensing iron-folic acid at every ANC visit is a required ANC activity in the Philippine DOH MNCHN strategy.
- Td immunization connects to the National Immunization Program (NIP) — Td for pregnant women is part of the expanded program on immunization (EPI) routinely given at RHU/BHS.
- DMPA and FP counseling link to the National Family Planning Program — the midwife at the BHS is a primary FP service provider; DMPA is one of the most commonly administered FP methods in Philippine community settings.
- The 'limited formulary' concept is directly tested in MLE Professional Practice questions about the scope and limitations of RA 7392 — understanding what a midwife CAN and CANNOT do is both a legal and clinical knowledge requirement.
- Cold chain connects to both vaccine administration AND oxytocin storage — oxytocin needs refrigeration (2–8°C), which is why misoprostol (heat-stable) is the AMTSL alternative in remote settings without electricity or refrigeration.
- MgSO4 toxicity and calcium gluconate connect to the safe administration principle of always having the antidote available — this parallels the anaphylaxis protocol (epinephrine must be on hand when giving any injectable drug).
Exam Strategy
For the MLE Pharmacology section, approach every drug question with THREE filters: (1) SCOPE — Is this drug within the midwife's authorized formulary under RA 7392? If uncertain, default to 'detect and REFER.' (2) INDICATION — Is it for normal birth support, prevention of a defined deficiency, immunization, or emergency first-aid (loading dose only)? Any drug that treats a disease = physician territory. (3) SAFETY PARAMETERS — Know the exact dose, route, timing, contraindications, and monitoring for every drug in the formulary. The MLE loves testing exact numbers: oxytocin 10 IU IM (1 min), Vitamin K1 1 mg or 0.5 mg, iron 60 mg + folic acid 400 mcg, Td 0.5 mL, DMPA 150 mg every 3 months, MgSO4 4 g IV + 10 g IM, calcium gluconate 1 g IV. For scenario-type questions involving complications (eclampsia, severe PPH, hypertension): the answer structure is almost always 'give [loading/first-aid drug] + IMMEDIATELY REFER.' Never choose 'continue to manage at BHS level' for a complication. Use the mnemonic R-U-K for MgSO4 safety monitoring. For AMTSL, remember the three-component sequence. For the prohibited categories, remember: oxytocin to speed up labor = NEVER; ergometrine in hypertension = NEVER; ongoing antibiotics independently = NEVER. Spend extra review time on MgSO4 (loading dose, safety signs, antidote) and AMTSL (oxytocin dose, timing, AMTSL 3 steps) as these are consistently the highest-yield pharmacology topics in the midwifery board examination.
Quick Review Questions
What is the drug of choice for AMTSL, the dose, route, and timing?
Oxytocin is preferred because it is effective and does NOT raise blood pressure, making it safe even when the woman's BP is elevated or unknown. This is the cornerstone of preventing PPH, the #1 cause of maternal death in the Philippines.
Why is ergometrine contraindicated in a woman with pre-eclampsia?
This is one of the most commonly tested drug-specific contraindications in the MLE. Ergometrine (0.2 mg IM) is only second-line for PPH and must never be given if the woman has hypertension, pre-eclampsia, eclampsia, or heart disease.
What is the Vitamin K1 dose and injection site for a term newborn versus a preterm newborn weighing 1.3 kg?
The injection site for all newborn IM injections is the anterolateral thigh — the vastus lateralis muscle — NOT the deltoid. The dose differs based on birth weight to prevent VKDB (Vitamin K Deficiency Bleeding).
A nursing mother at 6 weeks postpartum requests oral contraceptive pills. Which type is most appropriate and why?
Combined Oral Contraceptives (COCs) contain estrogen, which suppresses breast milk production and is passed to the infant. POPs contain only progestin and are safe during breastfeeding. DMPA (injectable, 150 mg IM every 3 months) is also an excellent progestin-only choice for lactating women.
What are the three safety signs the midwife must check before and during MgSO4 administration?
If ANY of these safety signs is abnormal (RR < 12, oliguria, absent knee-jerk), MgSO4 must be STOPPED immediately and the antidote calcium gluconate 1 g (10 mL of 10% solution) slow IV must be given.
What is the MgSO4 loading dose for eclampsia and what is the antidote for MgSO4 toxicity?
The midwife gives the LOADING DOSE ONLY as a pre-referral stabilizing measure before urgent transport to a BEmONC/CEmONC facility. The maintenance dose (5 g IM every 4 hours) is the physician's responsibility at the hospital.
A pregnant woman asks if she can take a Vitamin A supplement she received from a food aid program. The supplement label says 50,000 IU. What should the midwife advise?
High-dose Vitamin A (≥10,000 IU/day) is absolutely contraindicated during pregnancy due to teratogenicity. The postpartum dose (200,000 IU as a single capsule) is given to the MOTHER AFTER delivery, not during pregnancy. Low-dose Vitamin A in prenatal multivitamins is safe.
Which TT/Td dose first provides protection for the current pregnancy, and how long after TT1 must it be given?
TT1 alone gives NO protection. TT2 (given ≥4 weeks after TT1) provides approximately 3 years of protection and protects the current pregnancy and newborn from neonatal tetanus. Each subsequent dose extends protection duration up to lifetime protection at TT5.
A doctor is not available at the BHS. A woman in active labor appears to have a prolonged second stage. Is the midwife authorized to set up an oxytocin drip to augment labor?
Using oxytocin before the baby is born (to induce or augment labor) can cause uterine hyperstimulation, uterine rupture, and fetal death. The midwife's correct action is to REFER the woman to a physician/facility immediately while monitoring mother and baby and documenting the referral.
What is the DOH standard iron-folic acid supplementation for a pregnant woman without anemia?
Iron prevents and treats anemia (the most common nutritional deficiency in pregnancy in the Philippines); folic acid prevents neural tube defects. The dose is increased to twice daily for women with confirmed anemia. The 3-month postpartum continuation replenishes iron stores lost during pregnancy and delivery.
Ready to practise for the Midwife Licensure Exam 2026?
Super Tutor's AI review plan adapts to your weak areas and builds a weekly practice schedule around your target Midwife Licensure Exam exam date.